newsfilter
← Latest News
PR Newswire·

Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update

Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with...